Over-expression of the human MDM2 p53 binding domain by fusion to a p53 transactivation peptide

Area of Science:

• Molecular Biology
• Protein Expression and Purification

Background:

• MDM2 protein negatively regulates the tumor suppressor p53.
• The MDM2 p53 binding domain is crucial for this interaction but difficult to express in sufficient quantities for research.

Purpose of the Study:

• To develop an optimized bacterial expression system for the MDM2 p53 binding domain.
• To enhance the yield and simplify the purification of this key protein fragment.

Main Methods:

• Constructed a fusion protein by linking the p53 transactivation peptide (residues 17-29) to the N-terminus of the MDM2 p53 binding domain (residues 5-109).
• Introduced a tobacco etch virus protease recognition site for cleavage.
• Incorporated point mutations (F19A or W23A) in the p53 peptide to facilitate separation.

Main Results:

• Achieved a >200-fold increase in soluble expression of the MDM2 p53 binding domain in bacteria.
• Demonstrated high yield and straightforward purification of the target protein.
• The engineered construct facilitates efficient production of the MDM2 p53 binding domain.

Conclusions:

• The novel fusion construct significantly overcomes previous limitations in expressing the MDM2 p53 binding domain.
• This optimized system provides a high-yield, easily purified source of the MDM2 p53 binding domain for biochemical and structural studies.